Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Oncotarget|January 23, 2014
GATA2 as a potential metastasis-driving gene in prostate cancerYan Ting Chiang, Kendric Wang, Ladan Fazli, et al.Plos One|February 15, 2013
BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cellsChristopher G Low, Iris S U Luk, Dong Lin, et al.Cancer Chemotherapy and Pharmacology|December 24, 2008
The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazineJun Guan, Maisie Lo, Peter Dockery, et al.Gynecologic Oncology|December 14, 2004
Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential modelsCheng-Han Lee, Hui Xue, Margaret Sutcliffe, et al.Molecular Oncology|January 7, 2014
Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft modelSifeng Qu, Kendric Wang, Hui Xue, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2016
The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate CancerStephen Yiu Chuen Choi, Hui Xue, Rebecca Wu, et al.International Journal of Cancer|February 15, 2018
Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer modelSifeng Qu, Hui Xue, Xin Dong, et al.Oncotarget|July 30, 2014
The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosisSze Ue Iris Luk, Hui Xue, Hongwei Cheng, et al.British Journal of Cancer|January 31, 2018
Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancerSifeng Qu, Xinpei Ci, Hui Xue, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 5, 2013
Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistanceXin Dong, Dong Lin, Chris Low, et al.Pageof 5